STOCK TITAN

[Form 4] eHealth, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.

eHealth, Inc. director Francis S. Soistman Jr. received an annual equity award of 61,041 restricted stock units (RSUs) as compensation for service as a non-employee director. Each RSU represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in four equal quarterly installments starting on June 18, 2026, subject to his continued status as a Service Provider under eHealth's Amended and Restated 2024 Equity Incentive Plan. Any then-unvested RSUs will vest in full immediately before the next annual stockholder meeting or upon a Change in Control, subject to continued service. Following this grant, Soistman directly holds 1,089,814 shares of eHealth common stock.

Positive

  • None.

Negative

  • None.

Insights

Director receives time-based RSU grant as routine equity compensation.

Director Francis S. Soistman Jr. was granted 61,041 RSUs as an annual award for non-employee directors. The grant price is $0.00 per share because RSUs are compensation, not an open-market purchase, and each unit can settle into one common share upon vesting.

The RSUs vest in four equal quarterly installments beginning on June 18, 2026, contingent on continued service. Unvested RSUs accelerate immediately before the next annual stockholder meeting or upon a Change in Control, as defined in the 2024 Equity Incentive Plan. This structure encourages board retention while providing protection if control changes.

After this award, Soistman holds 1,089,814 shares directly. Because this is a scheduled equity grant at no cash cost, it is best viewed as standard director compensation rather than a market signal about eHealth’s future prospects.

Insider SOISTMAN FRANCIS S JR
Role null
Type Security Shares Price Value
Grant/Award Common Stock 61,041 $0.00 --
Holdings After Transaction: Common Stock — 1,089,814 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 61,041 shares Annual award of restricted stock units to non-employee director
Grant price per share $0.00 per share Compensation grant, not an open-market purchase
Shares after transaction 1,089,814 shares Total eHealth common shares directly held after the RSU grant
Vesting installments 4 installments RSUs vest in four equal quarterly tranches from June 18, 2026
restricted stock units ("RSUs") financial
"This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Service Provider financial
"subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan"
Amended and Restated 2024 Equity Incentive Plan financial
"as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")"
Change in Control financial
"or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan)"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SOISTMAN FRANCIS S JR

(Last)(First)(Middle)
C/O EHEALTH, INC.
9190 PRIORITY WAY WEST DR., SUITE 110

(Street)
INDIANAPOLIS INDIANA 46240

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
eHealth, Inc. [ EHTH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/18/2026A61,041(1)A$01,089,814D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date.
Remarks:
/s/ Sonwha Lee as attorney-in-fact for Francis S. Soistman06/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did eHealth (EHTH) director Francis Soistman report in this Form 4?

He reported receiving an annual grant of 61,041 restricted stock units (RSUs) of eHealth common stock as compensation for serving as a non-employee director, with no cash paid per share for the award.

How many eHealth (EHTH) shares does Francis Soistman hold after this RSU grant?

After the RSU grant, Francis Soistman directly holds 1,089,814 shares of eHealth common stock. This figure includes the impact of the new award as reported in the Form 4 filing.

What is the vesting schedule for the 61,041 eHealth RSUs granted to Francis Soistman?

The 61,041 RSUs vest in four equal quarterly installments starting on June 18, 2026, subject to Soistman’s continued status as a Service Provider under eHealth’s Amended and Restated 2024 Equity Incentive Plan.

What happens to Francis Soistman’s unvested eHealth RSUs if there is a Change in Control?

If eHealth undergoes a Change in Control, any then-unvested RSUs granted to Soistman will vest in full, provided he remains a Service Provider through that vesting date, according to the Plan’s terms.

Is this eHealth Form 4 transaction an open-market stock purchase by Francis Soistman?

No, this transaction is a grant of restricted stock units at $0.00 per share, not an open-market purchase. It represents equity compensation awarded for his service as a non-employee director.

Why were 61,041 RSUs granted to eHealth director Francis Soistman?

The 61,041 RSUs represent an annual equity award to eHealth’s non-employee directors. Such grants are designed to compensate directors and align their interests with shareholders through time-based vesting in company stock.